Today's guest post comes from Gerard Rivera, Co-Founder & CEO at RIS Rx. Gerard Rivera examines how copay programs and real-time gross-to-net (GTN) revenue protection can work together to support patient access and program performance. He highlights how simpler program design, timely data, and responsive action can help manufacturers manage affordability programs while preserving patient experience. To learn more about RIS Rx's gross-to-net (GTN) revenue protection solution, get a custom GTN assessment from RIS Rx. Read on for Gerard's insights. Read more » © 2006-2026 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. All rights reserved.…
Today's guest post comes from Gerard Rivera, Co-Founder & CEO at RIS Rx.
Gerard Rivera examines how copay programs and real-time gross-to-net (GTN) revenue protection can work together to support patient access and program performance. He highlights how simpler program design, timely data, and responsive action can help manufacturers manage affordability programs while preserving patient experience.
To learn more about RIS Rx's gross-to-net (GTN) revenue protection solution,
get a custom GTN assessment from RIS Rx.
Read on for Gerard's insights.
Read more »
US Pharma Marketing
